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Abstract
Mastitis caused by Escherichia coli and Staphylococcus aureus is a major pathology of dairy cows. To better
understand the differential response of the mammary gland to these two pathogens, we stimulated bovine
mammary epithelial cells (bMEC) with either E. coli crude lipopolysaccharide (LPS) or with S. aureus culture
supernatant (SaS) to compare the transcriptomic profiles of the initial bMEC response. By using HEK 293 reporter
cells for pattern recognition receptors, the LPS preparation was found to stimulate TLR2 and TLR4 but not TLR5,
Nod1 or Nod2, whereas SaS stimulated TLR2. Biochemical analysis revealed that lipoteichoic acid, protein A and
α-hemolysin were all present in SaS, and bMEC were found to be responsive to each of these molecules.
Transcriptome profiling revealed a core innate immune response partly shared by LPS and SaS. However, LPS
induced expression of a significant higher number of genes and the fold changes were of greater magnitude than
those induced by SaS. Microarray data analysis suggests that the activation pathways and the early chemokine and
cytokine production preceded the defense and stress responses. A major differential response was the activation of
the type I IFN pathway by LPS but not by SaS. The higher upregulation of chemokines (Cxcl10, Ccl2, Ccl5 and Ccl20)
that target mononuclear leucocytes by LPS than by SaS is likely to be related to the differential activation of the
type I IFN pathway, and could induce a different profile of the initial recruitment of leucocytes. The MEC responses
to the two stimuli were different, as LPS was associated with NF-κB and Fas signaling pathways, whereas SaS was
associated with AP-1 and IL-17A signaling pathways. It is noteworthy that at the protein level secretion of TNF-α
and IL-1β was not induced by either stimulus. These results suggest that the response of MEC to diffusible stimuli
from E. coli and S. aureus contributes to the onset of the response with differential leucocyte recruitment and
distinct inflammatory and innate immune reactions of the mammary gland to infection.
Introduction
Mastitis is ranked as the top disease for dairy cattle on
the basis of incurred economic losses [1,2]. Escherichia
coli and Staphylococcus aureus are two major pathogens
causing mammary infections of dairy ruminants. Most
cases of E. coli mastitis are clinical and of short duration,
in general less than 10 days, because the inflammatory
reaction is usually able to clear the infection [3]. In
contrast, S. aureus mastitis may manifest very diverse
degrees of severity, from fulminating gangrenous mas-
titis with nervous systemic signs to mild local infection
with only local signs [4]. In the cow, most strains are as-
sociated with infection that often leads to chronic mas-
titis lasting several months [4]. Experimentally induced
E. coli mastitis is characterized by high concentrations of
chemokines and cytokines in milk, whereas these inflam-
matory mediators, and in particular the chemokine
CXCL8 and the cytokine TNF-α, are undetectable or in
low concentrations in case of S. aureus mastitis [5,6].
Once they have entered the lumen of the mammary
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gland through the teat canal, these bacteria are able to rep-
licate rapidly in milk. A rapid and robust response of the
mammary gland is needed for the control of these fast-
growing microbial invaders. Consequently, the prompt de-
tection of pathogens by the innate immune system is of
prime importance, and because mammary epithelial cells
(MEC) are in the front line, they could play an important
role as sentinels. Several studies have showed that MEC
are poised to respond quickly to bacterial intrusion
through the activation of several Pattern Recognition Re-
ceptors (PRR) by the so-called Microbe-Associated Mo-
lecular Patterns (MAMP). MEC are equipped with several
sensors of bacteria, and they are able to react by producing
mediators of inflammation and local defense [7-9]. Thus,
an important research issue is to define how MEC play
their role of sentinel of the mammary gland.
The main objective of our study was to characterize
the differences in the response of MEC to E. coli versus
S. aureus at the onset of infection, which could impact
the triggering of the inflammatory and immune re-
sponses of the mammary gland.
A number of studies have shown that bovine MEC in
culture are able to sense bacteria or bacterial products,
and to react by up-regulating several sets of genes involved
in the innate immune response [10-13]. Although a great
deal of information has been gathered, the innate immune
sensing of S. aureus or E. coli in the mammary gland and
the induced immune responses are not completely under-
stood. These processes are of crucial importance because
they can lead to either effective antibacterial responses or
harmful side-effects of inflammation. We set out to study
the response of bovine MEC to components of E. coli and
S. aureus with a view to uncovering some of the reasons
that could account for the contrasted responses of the
udder to these two pathogens.
Most of the studies that have shown that bMEC re-
spond differently to E. coli and S. aureus were based on
in vitro exposure of isolated bMEC to killed bacteria or
purified bacterial MAMP [10,11,14,15]. It is known that
the nature of the stimulus, i.e. live or killed bacteria or
purified MAMP, elicits somewhat different responses
from target cells [16,17]. These may reflect the sequen-
tial host-pathogen dialogue that occurs as bacteria begin
to multiply in milk following intrusion into the lumen of
the mammary gland. Bacteria are probably first detected
by host sensors through the release of soluble and par-
ticulate factors which increase during bacterial stress, as
it might be expected in the early stages of bacterial
colonization of the mammary gland. These complex in-
teractions which occur prior to the detectable onset of
the inflammatory response are likely to determine the
ultimate outcome in terms of pathogenic sequelae lead-
ing to acute or chronic mastitis. However, relatively little
is known about the initial host response to these factors.
We chose to tackle the issue by using complex mixtures
of bacterial components rather than live bacteria. In the
mammary gland at the onset of infection, sentinel cells are
confronted by bacterial bodies (mostly live bacteria), and
by products secreted by bacteria. Turnover of peptidogly-
can in the course of replication, active secretion of
exoproteins (toxins, proteases) or shedding of surface
proteins released by proteases (adhesins, other surface
proteins) or other mechanisms such as extrusion of mem-
brane particles are involved in the release of bacterial prod-
ucts [18,19]. Thus, the response of sentinel cells probably
results from the combination of bacterial bodies and re-
leased diffusible products. However, when bacterial density
remains low in the lumen of the mammary gland, the bac-
terial components shed precociously during bacterial pro-
liferation, are likely to interact with more MEC than the
bacterial bodies themselves. Therefore in this study we fo-
cused our interest on the early response of MEC to these
bacterial factors. The objective was to mimic the onset of
intramammary infection (IMI) when the epithelium lining
initially makes contact with components of bacterial origin.
During growth, E. coli bacteria do not shed great amounts
of proteins or other soluble compounds, but they release
many outer membrane vesicles (omv) [19]. These omv are
complexes of LPS with proteins including lipoproteins. We
used E. coli crude LPS as a commercial substitute for omv.
In contrast to E. coli, S. aureus bacteria secrete a lot of pro-
teins along with insoluble particles during growth. Culture
supernatant from a mastitis-causing S. aureus (SaS) was
taken in this study as a source of staphylococcal released
bacterial products. To further our understanding of the
pathways involved in these early events, we compared the
responses of bMEC to crude LPS and to SaS by microarray
analysis. We found that more genes were differentially
expressed, and that the magnitude of expression was
higher, after stimulation with LPS than with SaS. A major
difference in the nature of the induced response was the
activation of the type I IFN pathway by LPS, but not
by SaS, with a concomitant overexpression of several genes
involved in either the recruitment of mononuclear
leucocytes or local defenses. The most affected activation
and functional pathways also differed. Overall, these results
strongly suggest that E. coli induces a more intense re-
sponse associated with strong NF-κB stimulation and the
recruitment of a wider repertoire of immune cells, whereas
S. aureus interferes with cell DNA integrity and may
induce a more restricted immune response involving the
IL-17A pathway.
Materials and methods
Bacterial agonists of bMEC
Four S. aureus strains were initially selected to prepare
SaS. Three of them (169.32, 628.24 and 644.15) were
from our mastitis strain collection, and were originally
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isolated from subclinical cases of mastitis. Some charac-
teristics of strains 628.24 and 644.15 are described else-
where [20]. The fourth strain, Newbould 305 (N305), was
originally isolated from a clinical case of bovine mastitis
and subsequently used as a model organism to experimen-
tally induce mastitis and study the inflammatory response
of the mammary gland or the response of bMEC [5,21,22].
On sheep blood agar plates, this strain is strongly alpha
and beta hemolytic. A few features of the four shortlisted
bacterial strains are given in Table 1. To prepare culture
supernatants, bacteria stored lyophilized or at −80°C were
cultivated overnight in Brain Heart Infusion broth, then
were grown overnight at 37°C in RPMI 1640/DMEM (1:1)
(Gibco, Invitrogen, Carlsbad, CA, USA). Finally, 50 mL of
RPMI 1640/DMEM was seeded with 0.5 mL of the over-
night culture, and incubated at rest in a 165 mL flask for
8 h at 37°C, or for different durations as indicated in the
Results section. Protein content of 8-h SaS was 40 μg/mL
for strains N305 and 169.32, and 20 μg/mL for strains
628.24 and 644.15, as measured with a micro-BCA assay
(Pierce, Thermo Scientific, Rockford, IL, USA).
Crude LPS (phenol extract, Escherichia coli O55:B5, cata-
log reference L-2880) was from Sigma-Aldrich (St-Louis,
MO, USA). Purified LPS from E. coli O111:B4 (ULPS),
purified staphylococcal lipoteichoic acid (LTA), synthetic
muramyl dipeptide (MDP), purified flagellin from Salmon-
ella enterica serovar Typhimurium and C12-iE-DAP were
from InvivoGen (Toulouse, France). Staphylococcal protein
A (SpA) was from Gentaur (GENTAUR Europe BVBA,
Brussels, Belgium) and recombinant Protein A from
MBL (JM-6500B) (Clinisciences, Nanterre, France). The
staphylococcal α-hemolysin was purified as previously de-
scribed [23,24].
Detection of MAMP with HEK293 cell lines
HEK-Blue™ reporter cells, which are stably transfected
with multiple human genes from the TLR2 (HEK-Blue-2)
or the TLR4 (HEK-Blue-4) pathways and with a reporter
gene monitoring NF-κB activation, were purchased from
InvivoGen. These cells were dispensed in 96-well plates
(2 × 104 per well) and cultured for 48 h. Then they were
incubated with either LPS or SaS and HEK-Blue detection
medium for 16 h. The presence of TLR2 or TLR4 agonists
induced the reduction of the medium which turned blue.
The blue color was quantified by measuring absorption at
650 nm. HEK293 cells stably transfected with either the hu-
man TLR5 gene, CARD4 gene (encoding the PRR NOD1)
or CARD9 gene (encoding NOD2) were from InvivoGen.
They were used as HEK-Blue reporter cells, except that at
the end of incubation with LPS or SaS (without HEK-Blue
detection medium), the cell culture supernatant was col-
lected and the CXCL8 content measured by ELISA as a
readout. Purified agonists of PRR (InvivoGen) were used in
parallel with LPS and SaS as positive and negative controls.
Characterization of SaS
Staphylococcal cultures were centrifuged and supernatants
were aseptically filtered on 0.2 μm filters and stored
at −80°C. Aliquots were saved for SaS characterization.
For each strain supernatant, protein concentration was de-
termined with the Micro-BCA protein assay. The protein
content was analyzed by SDS-PAGE on 12.5% polyacryl-
amide gel and ammoniacal silver staining. The presence of
specific components in staphylococcal supernatants, such
as LTA, SpA and α-hemolysin were revealed by immuno-
blotting using relevant antibodies, i.e. mouse monoclonal
antibody ab12248 to LTA from Abcam (Cambridge, UK),
chicken polyclonal antibody ab18598 to SpA from Abcam
and an in-house rabbit polyclonal antibody to α-toxin.
Pilot experiments were carried out for S. aureus strain
selection and SaS production. As staphylococcal strains
can vary greatly in their ability to stimulate cellular re-
sponses [25], we compared the response of MEC to 4 S.
aureus mastitis isolates, selected on the basis of their use
in previous studies [5,20]. In order to use early culture su-
pernatants, we determined the minimum culture duration
necessary to obtain a sizeable quantity and variety of pro-
teins. It appeared that for the 4 isolates 7 to 8 h of culture
were necessary to yield a reproducible pattern of proteins
as visualized by SDS-PAGE analysis (Additional file 1 and
results not shown). The 8-h culture corresponded to the
early stationary phase for the 4 strains (results not shown).
The 30–40 kDa zone was particularly rich in bands which
correspond to the range of molecular masses of hemoly-
sins and other toxins. The total quantity of proteins in the
8-h SaS was 40 μg/mL for strains N305 and 169.32, and
20 μg/mL for strains 628.24 and 644.15. To partially com-
pensate for this difference in concentration, bMEC were
Table 1 Features of S. aureus bacterial strains shortlisted for stimulation of bMEC
Strains Hemolysis phenotype Agr type Capsular type Leucotoxin titer LukS (ng/mL) Hla (μg/mL)
Newbould 305 hla+++ hlb+++ agr1 CP5 20 5 10
169.32 hla+++ hlb+++ agr2 CP8 120 50 5
628.24 hla- hlb- agr1 CP5 10 0 0.6
644.15 hla- hlb- agr1 CP5 5 0 0.6
Hla Alpha hemolysin, hlb Beta hemolysin, CP Capsular polysaccharide, LukS Small component of bi-component leucotoxins. Toxin titers and concentrations were
measured in 8-h culture supernatants.
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stimulated with 25% 8-h N305 or 169.32 SaS and 33% 8-h
628.24 or 644.15 SaS. After 8 h of exposure to SaS, CXCL8
concentrations were determined in cell culture super-
natant and transcripts of TNF-α were measured in MEC
extracts. Although MEC responded to all the SaS, the re-
sponse to N305 SaS was the greatest for the two indicators
(Additional file 1 and results not shown). Consequently,
the 8-h N305 SaS was selected for the study.
Depletion of LTA from SaS
In order to investigate whether LTA contributed to the ac-
tivation of MEC, SaS LTA content was reduced by affinity
adsorption by using Protein G Sepharose beads coated
with the anti-LTA mAb (Abcam) as described [26]. Briefly,
to deplete LTA from SaS bead pellet (50 μL) was incubated
for 3 h at room temperature under slight agitation with
100 μg of monoclonal ab12248. After centrifugation at
150 × g and five washing steps with HBSS, the activated
beads were incubated with SaS (500 μL) for 6 h at 4°C
under continuous shaking. Then the beads were removed
by centrifugation. Control SaS was prepared by incubating
SaS with uncoated beads.
MEC culture conditions and stimulation
Mammary tissue samples were collected from healthy
lactating cows of the INRA dairy facility (INRA,
Nouzilly) at culling. Cows were slaughtered according
to procedures approved by our Institutional Animal
Care and Use Committee (CREEA, Comité Régional
d’Ethique et d’Experimentation Animale). Bovine MEC
were isolated from five cows as previously described
and cryopreserved in liquid nitrogen [22]. When
needed, the cells were thawed and cultured in RPMI
1640/DMEM (1:1) (Gibco) supplemented with 10%
heat-treated FCS (Gibco), hydrocortisone (1 μg/mL),
40 mM HEPES (Cambrex Biowhittaker, East Ruther-
ford, NJ, USA), insulin (5 μg/mL), 1 mM sodium pyru-
vate, 2 mM glutamin, 100 U penicillin, streptomycin
(0.1 mg/mL), and amphotericin B (0.25 μg/mL). For the
microarray experiment, the cells from one cow were
seeded in 25 cm2 flasks (5 × 105 cells/flask) and cultured
until confluence in 5 mL of growth medium. The re-
sponse of this cell batch in terms of CXCL8 production
and TNF-α overexpression had proved to be representa-
tive of the other MEC prepared in our laboratory (re-
sults not shown). Cells were used at their third passage.
Twenty-four hours before stimulation, the growth
medium was replaced by a stimulation medium of the
same composition except that the FCS concentration
was lowered to 5% to reduce its influence on MEC re-
sponse, and hydrocortisone was omitted. For stimulation
of MEC with bacterial agonists, the medium was removed,
and 20 μg/mL crude LPS (O55:B5) or 25% (v/v) SaS N305
in stimulation medium were added at concentrations that
were supposed to induce robust responses on the part of
MEC. After incubation for 3 h and 6 h, cell culture super-
natant was removed and MEC were harvested for
RNA extraction.
For confirmation of the results of microarray analysis by
RT-qPCR, cells from 5 cows were seeded in 6-well tissue
culture plates (2 × 105 cells/well) and cultured until con-
fluence. MEC were incubated with 20 μg/mL crude LPS
or 25% SaS N305 in 2 mL of stimulation medium for 3 h
and 6 h. At the end of incubation, the cell culture medium
was aspirated and stored at −20°C and total RNA was
extracted from the MEC layer.
To check whether the differential response of MEC to
crude LPS compared to SaS involved the contribution of
type I interferon, MEC were incubated with recombinant
human IFN-β (produced in CHO cells; PeproTech, Rocky
Hill, NJ, USA). The response of MEC to IFN-β was evalu-
ated by RT-qPCR through the up-regulation of the
IFN-inducible genes Isg15 and Ccxl10, and appropriate
concentration and exposure time were determined. Then,
the effect of the exposure to 10 ng/mL IFN-β for 3 h be-
fore addition of SaS was determined by RT-qPCR after a
further 3-h incubation.
Assessment of viability of MEC
In the presence of 5% FCS, 8-h SaS N305 exerted moder-
ate cytotoxic effect on bMEC after overnight incubation,
whereas crude LPS did not cause any visual modification
when compared to control culture conditions. The short
term effect of LPS and SaS on the viability of MEC was
evaluated using the alamarBlue® (Biosource International
Camarillo, CA, USA) assay. MEC from 5 cows were cul-
tured to confluence in 24-well culture plates and incu-
bated for 3 h or 6 h with 10% alamarBlue in 1 mL of
culture medium with or without 5% FCS. Fluorescence
of the oxidation-reduction indicator was measured at
530 nm excitation wavelength and 590 emission wave-
length (Cytofluor 2300 System). The results are expressed
as means of the 5 cultures.
Quantification of CXCL8, TNF-α and IL-1β
Enzyme-linked immunosorbent assays (ELISA) were used
to measure cytokine concentrations in culture superna-
tants of MEC stimulated with LPS or SaS. The ELISA for
bovine TNF-α and CXCL8 were performed as previously
described [27,28]. Commercially available kits were used
according to the manufacturer’s instructions to measure
bovine IL-1β (Thermo scientific, Rockford, IL, USA)
and human CXCL8 (Development kit, Peprotech). Quan-
tifications of proteins by ELISA were performed on cell
culture supernatants after 6 or 16 h of incubation with
the agonists.
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RNA extraction and quality assessment
Total RNA was extracted by a double extraction method
first using Trizol (InvitroGen) and then RNeasy (Qiagen,
Valencia, CA, USA) column purification. RNA quantifica-
tion was performed using a spectrophotometer (NanoDrop
Technologies) and RNA integrity was assessed using an
Agilent Bioanalyzer 2100 (Agilent Technologies, Inc., Santa
Clara, CA, USA) with a RNA Integrity Number (RIN)
value > 7.0. The residual genomic DNA was removed by
DNA digestion with RNase-free DNase (Qiagen).
Microarray experiment and analysis
Sixteen microarrays (2 stimuli * 2 times * quadruplicate)
were hybridized using the ARK-Genomics 17 K slide
(ArrayExpress accession number A-MEXP-1592) in a
two-color dye swap experimental design (Additional file
2). RNA labeling was carried out with the fluorescent cya-
nine dyes Cy3 or Cy5 and hybridizations performed in a
GeneTac automated hybridization station (Genomic Solu-
tions) as described previously [29]. The data were
extracted using BlueFuse [30]. Raw data were imported in
R for filtering and normalization. Data were first filtered
according to spot quality (uniformity and saturation) pro-
vided by BlueFuse. Spots with the worst quality (flag = E
and quality = 0) were excluded, resulting in a removal rate
of 33% to 45% per slide. Lowess normalization commonly
used to correct the dye bias effect was not applied since
MA-plots did not show any significant deviation from lin-
earity. The log2-intensity of each dye was analyzed separ-
ately, since Bossers et al. [31] showed that this method
enhances the reproducibility and the sensitivity of the de-
tection of differentially expressed genes. Data were then
reduced and centered within slide (mean intensity equal
to zero and variance equal to one on average for the spots
of one slide) to allow comparison across slides. Differences
of expression between conditions were analyzed probe by
probe by analysis of variance (ANOVA) using the SAS
MIXED procedure. Probes with less than 16 observations
were excluded from the analysis, resulting in an average of
28.5 observations per probe (± 9). Finally, 9559 probes
and 272 770 observations (per dye) were retained. The
ANOVA model included the fixed effect of color and the
effect of the combination between stimulation (LPS, SaS
and reference) and time (3 h, 6 h). The p-values of the
tests were corrected with a 1% false discovery rate (FDR)
with Benjamini-Hochberg correction [32]. Fold-changes
(FC) were computed as the exponential (base 2) of the
ANOVA-estimated-log2-intensity-ratio of samples from
two conditions. The data discussed in this publication
have been deposited in NCBI’s Gene Expression Omnibus
and are accessible through GEO series accession number
GSE47599.
To reveal functional connections between the regu-
lated transcripts, a network and pathway analysis of the
differentially expressed genes was performed by using
Genomatix GePS (Genomatix Software GmbH, Munich,
Germany). Lists of differentially expressed genes were in-
put into the system with human ortholog gene names,
along with their fold changes. Signal transduction path-
ways such as canonical and proprietary (Genomatix), mo-
lecular functions (Gene Ontology) and biological
processes (GO) were listed provided the associated p value
was > 10-5 (the threshold was lowered to 10-4 whenever
none were > 10-5), and the number of genes in the list
falling in the pathway > 5.
Reverse transcription and PCR analysis (RT-qPCR)
From the samples used in the microarray analysis, total
RNA was reverse transcribed to cDNA: 1 μg of RNA was
incubated with 1 μg of random primers (Promega, Madi-
son, WI, USA) for 10 min at 65°C and then for 5 min on
ice in a final volume of 10 μL. Reverse transcription was
carried out by adding avian myeloblastosis virus (AMV)
reverse transcriptase buffer (Promega), 4 mM deoxy-
nucleoside triphosphate (dNTP) (Promega), 15 U of AMV
reverse transcriptase (Promega), and 40 U of RNasin
(Promega) to the mixture. The mixture was incubated for
1.5 h at 42°C and 5 min at 95°C. Diluted cDNA samples
were stored at 4°C until use. The same cDNA samples were
used for microarray and qPCR determinations.
All primers (Table 2) used in this study were designed by
using Clone Manager 9 (Scientific & Educational Software,
Cary, NC, USA) using publicly available bovine sequences
and were purchased from Eurogentec (Liège, Belgium).
Primers were designed to span an intron-exon boundary to
prevent the amplification of genomic DNA. Relative quan-
tities of gene transcripts were measured by qPCR using the
SYBR Green I fluorophore (Roche Diagnostics, Mannheim,
Germany) as described previously [33].
Statistical analyses
Statistical analyses were performed with the StatXact soft-
ware (Cytel software Corp., Cambridge, MA, USA) or the
Prism software (version 5.0; GraphPad). A probability level
of < 0.05 was considered significant. Comparisons of
paired samples were done with the Friedman test followed
by Bonferroni post-test comparison and the comparison
of unpaired samples with the Kruskal-Wallis test.
Results
Detection of PRR agonists in the LPS and SaS
preparations
Because E. coli is sensed by sentinel cells of the immune
system through activation of several PRR [34], we used a
crude LPS preparation to stimulate bMEC. We investi-
gated the presence of agonists of TLR2, TLR4, TLR5,
Nod1, and Nod2 in the LPS preparation by incubating
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HEK293 cells transfected with the corresponding human
PRR. We found that the crude LPS preparation activated
HEK293 cells transfected withTLR2 and TLR4 (Figure 1a),
but not TLR5, Nod1, and Nod2 (Figure 1b).
By using the same HEK 293 reporter cells, we found that
8-h SaS contained activators of TLR2 but not TLR4 or
TLR5, and did not activate Nod1 or Nod2 (Figure 1a and
b). As S. aureus N305 produces several toxins, including
alpha hemolysin which is known to be cytotoxic, we deter-
mined whether SaS altered the metabolism of MEC under
our culture conditions by using an indicator of chemical
reduction of growth medium (alamarBlue). Neither 25%
(v/v) 8-h SaS nor LPS (20 μg/mL) induced a significant
effect on the activity of MEC after 3 h and 6 h of incuba-
tion, indicating that MEC were neither impaired nor acti-
vated (Additional file 3).
Table 2 Gene-specific oligonucleotide primers used for qPCR
Gene symbol Oligonucleotides (5′-3′) Amplicon Annealing Accession
F: forward ; R: reverse (bp) Temperature (°C) number (GenBank)
18 s rRNA F: CGGGGAGGTAGTGACGAAA 196 69 AF176811
R: CCGCTCCCAAGATCCAACTA
TNFa F:TCTTCTCAAGCCTCAAGTAACAAGC 104 69 EU276079
R: CCATGAGGGCATTGGCATAC
Il6 F: TGCTGGTCTTCTGGAGTATC 153 62 EU276071
R: GTGGCTGGAGTGGTTATTAG
Ccl2 F: GCTCGCTCAGCCAGATGCAA 117 62 NM174006
R: GGACACTTGCTGCTGGTGACTC
Ccl5 F: CTGCCTTCGCTGTCCTCCTGATG 217 62 NM175827
R: TTCTCTGGGTTGGCGCACACCTG
Ccl20 F: TTCGACTGCTGTCTCCGATA 172 62 NM174263
R: GCACAACTTGTTTCACCCACT
CD83 F: GAA GGG CAG AGA AAC CTG AC 231 65°C BC112861
R : AGA GGT GAC TGG GAG GAA AG
Nos2 F: CTT GAG CGA GTG GTG GAT GG 240 64 NM001076799
R: CCT TCA TCC TGG ACG TGG TTC
Isg15 F: CGC-CCA-GAA-GAT-CAA-TGT-GC NM_174366
R: TCC-TCA-CCA-GGA-TGG-AGA-TG 158 62
Cxcl10 F: TTC-AGG-CAG-TCT-GAG-CCT-AC 218 62 NM_001046551
R: ACG-TGG-GCA-GGA-TTG-ACT-TG
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Figure 1 Activity of crude LPS (LPS Sigma) and SaS (SaS N305) on HEK 293 cells transfected with human TLR2, TLR4, TLR5, Nod1 or
Nod2. a) Pure LPS (ULPS) and purified LTA were used as agonists of TLR4 and TLR2, respectively. The response of HEK Blue cells (InvivoGen) was
measured spectrophotometrically (OD 630 nm). b) Flagellin, C12-iE-DAP and MDP were used as agonists of TLR5, Nod1 and Nod2, respectively.
The response of HEK 293 cells was evaluated through secretion of CXCL8, measured by ELISA.
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Anticipating that SaS contains multiple bacterial compo-
nents including exoproteins, lipoproteins and PGN deriva-
tives that are susceptible to stimulate MEC, we verified the
presence of some of these components and determined
their capacity to activate MEC. We used the secretion of
CXCL8 as a readout for MEC stimulation experiments.
Since the response of HEK293 -TLR2 cells indicated that
SaS contains at least one agonist of TLR2, we looked for
the presence of LTA, which is supposed to be sensed by
TLR2 in association with CD36 [35] and is able to activate
bMEC [10,33]. SaS was submitted to SDS-PAGE and
immunoblotted with a mAb against LTA, along with puri-
fied staphylococcal LTA. The immunoblotting revealed a
smear comparable to that of purified LTA, which by com-
parison with known LTA concentration was estimated to
be 1 to 2 μg/mL (Figure 2a). Depletion experiments were
carried out to investigate whether LTA contributed to the
response of MEC to SaS. Incubation of SaS with beads
coated with the anti-LTA mAb was efficient in depleting
SaS of LTA, and this depletion correlated with a reduced
stimulating activity of SaS on bMEC (Figure 2a and b).
This showed that LTA is likely to contribute to the activa-
tion of MEC, but suggests that other staphylococcal prod-
ucts play a part in the stimulation.
Since staphylococcal protein A (SpA) is able to induce
a pro-inflammatory response in human epithelial cells
[36], we looked for the presence of SpA in SaS. SDS-
PAGE followed by immunoblotting revealed the pres-
ence of SpA in 8-h SaS (Figure 2c). We then investigated
whether bMEC responded to SpA, because we did not
find previously published evidence of recognition of SpA
by these cells. Incubation of bMEC with increasing con-
centrations of either recombinant or native purified SpA
induced increasing secretion of CXCL8, indicating that
bMEC reacted to SpA (Figure 2d).
It has been shown that epithelial cells detect the presence
of bacterial pore-forming toxins such as staphylococcal he-
molysin alpha [37]. As S. aureus N305 produces high
amounts of α-hemolysin and as we did not find published
evidence that S. aureus α-hemolysin induced a pro-
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Figure 2 Detection of MAMP in SaS and effect on MEC. a) Detection of LTA in SaS. SaS (50 μL) was submitted to SDS-PAGE and
immunoblotted with a mAb to LTA (track 1). LTA appeared as a smear owing to its size heterogeneity as a result of varied number of
glycerolphosphate units. Immunoblotting was also performed with SaS treated with proteinase K (track 2) or with purified S. aureus LTA (250 ng
or 150 ng, tracks 3 and 4). SaS was depleted of LTA with beads coated with mAb to LTA (track 5). High molecular weight bands are the mAb
light and heavy chains. SaS treated with control beads without mAb is shown (track 6). b) MEC were incubated for 16 h with SaS (25%) treated
with control beads or with mAb-coated beads, and concentrations of CXCL8 in cell culture supernatants measured by ELISA. Purified LTA
(250 ng/mL) was added to the depleted SaS to restore activity. c) Staphylococcal protein A (SpA) was detected in SaS and was able to stimulate
bMEC. Immunoblot of 8-h N305 SaS revealed with a peroxidase-conjugated rabbit antiserum reacting with SpA; d) bMEC were incubated for 6 h
with either recombinant SpA or purified SpA, and CXCL8 concentrations measured in the cell culture supernatant by ELISA. e) Dose–response of
bMEC to decreasing concentrations of staphylococcal alpha hemolysin. Bovine MEC were incubated with purified alpha hemolysin for 16 h, and
CXCL8 was measured in cell culture supernatant by ELISA. To investigate the heat-resistance of the stimulus, alpha hemolysin was heated at 95°C
for 10 min.
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inflammatory response in bMEC on its own, we investi-
gated the capacity of purified α-hemolysin to induce the
secretion of CXCL8 by MEC. We found that bMEC
responded to α-hemolysin by secreting CXCL8 in a dose–
response manner (Figure 2e). This activity was heat-labile,
which suggests that it was not the result of the contamin-
ation of the toxin preparation with MAMP (Figure 2e).
Overall, these experiments indicate that N305 SaS con-
tains several bacterial compounds that are able to stimu-
late bMEC, and identified LTA, SpA and α-hemolysin, as
three of its active components which interact with differ-
ent sensors which activate downstream pathways.
Transcriptome profiling of the response of bMEC to LPS
preparation and SaS
The reaction of MEC to LPS and SaS was investigated
through gene expression profiling at a rather early time
post-exposure in order to gain insight into the response
of the cells likely to contribute to the triggering of the
inflammatory response.
Data were validated for 9559 probes on the basis of the
Reml with a Benjamini-Hochberg correction of 1%. Micro-
array analysis of bMEC RNA obtained 3 h and 6 h post-
exposure to LPS or SaS revealed differential expression of
hundreds of genes by comparison with unstimulated cells
(Additional file 4). More genes were differentially expressed
at 6 h than at 3 h post-exposure, and following exposure to
LPS than to SaS (Table 3). Also, the proportion of down-
regulated genes was higher with SaS than with LPS at 6 h
post-exposure (Table 3). There was a marked time effect
on the expression of genes because only 44 out of 382 and
182 out of 849 differentially expressed genes (DEG)
belonged to the sets of genes expressed 3 h and 6 h after
exposure to SaS or LPS, respectively (Figure 3). Most of
the up-regulated genes differed also as a function of the
stimulus at both 3 h and 6 h post-exposure (Figure 3). The
shared up-regulated genes coded mainly for chemokines,
cytokines, or molecules associated with the inflammatory
and immune response (Figure 3).
On the basis of annotation to human or mouse
orthologs and information obtained using NCBI and
InnateDB [39], the most differentially expressed genes
were distributed in categories related to different bio-
logical processes (Tables 4 and 5). From the lists of the
most highly up-regulated genes at 3 h and 6 h of incuba-
tion with either LPS or SaS, a few indications can be
drawn: i) Fold changes were higher with LPS than with SaS,
which reflects a stronger response to LPS than to SaS; ii)
chemokines were highly represented among the most up-
regulated genes. Chemokines with the ELR motif preceding
the first two cysteines (ELRCXC chemokines), which target
mainly neutrophils, were strongly up-regulated (CXCL1,
CXCL2, CXCL3, CXCL8). Notably, several chemokines
which target monocytes and lymphocytes, namely CCL2,
CCL5 and CCL20, were also up-regulated. iii) A distinctive
feature of the response of bMEC to LPS was the involve-
ment of IFN-related genes and IFN-β itself, which were not
up-regulated by SaS. iv) a characteristic of the bMEC re-
sponse to SaS was the up-regulation of genes implicated in
the regulation of transcription and activation pathways, and
in particular the NF-κB pathway, among the most up-
regulated genes (Table 4). A further difference between re-
sponses to LPS and SaS was the greater occurrence of
down-regulated genes in response to SaS (Table 4). Another
difference was that genes encoding proteins of the activator
protein-1 (AP-1) complex were up-regulated by SaS, but
not by LPS. In contrast, Fos was down-regulated at 6 h
by LPS.
In the cytokine and chemokine category, more genes
were up-regulated by LPS than by SaS. The difference was
most striking in the cytokine category, which was repre-
sented only by IL6 with SaS stimulation. The case of IFN-
β is of particular interest, because a number of genes re-
lated to the type I IFN-pathway were upregulated follow-
ing exposure to LPS, but not to SaS.
A number of genes associated with the immune defense
response, and in particular with innate immunity, were
up-regulated by both LPS and SaS. Again, more genes
were up-regulated after exposure of bMEC to LPS than to
SaS. Genes associated with cell growth, cell cycle, apop-
tosis or stress response were also involved in the response
to LPS or SaS (Tables 4 and 5).
We had anticipated that the response of bMEC would
differ substantially with the duration of incubation with
bacterial agonists. Indeed, higher numbers of genes were
differentially regulated with the 6-h incubation than with
the 3-h incubation, with the highest differences for up-
regulated genes for LPS and down-regulated genes for SaS
(Table 2). On the contrary, many of the genes most regu-
lated by exposure to LPS at 3-h were also highly regulated
at 6-h (Table 4). This was not true after exposure to SaS,
because a substantial proportion of the differentially
expressed genes (DEG) at 3-h differed from those at 6-h
(Table 5). After exposure to both LPS and SaS, genes cod-
ing transcription factors, cytokines or chemokines tended
to be more up-regulated at 3-h than at 6-h, whereas genes
associated with immune defense response, type I IFN
(for LPS), stress response and cell cycle tended to be more
up-regulated at 6-h than at 3-h (Tables 4 and 5). Overall,
this suggests that the activation pathways and the early
Table 3 Number of differentially expressed genes (DEG)
as a function of stimulus and duration of exposure
DEG Sas vs
Ref 3 h
SaS vs
Ref 6 h
LPS vs
Ref 3 h
LPS vs
Ref 6 h
Up-regulated 103 104 201 541
Down-regulated 7 212 16 273
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chemokine and cytokine production preceded the defense
and stress responses, which was not unexpected.
A functional analysis of the genes up-regulated after
stimulation was performed with Genomatix GePS to dis-
play canonical pathways and to create networks. In
response to LPS, most of the highest ranking signal trans-
duction pathways, molecular functions and biological pro-
cesses were connected to inflammatory and immune
responses (Table 6). In contrast, the signal transduction
pathways associated with the response of MEC to SaS at
6 h post-exposure were connected with cell cycle and
DNA repair (Table 7). Nevertheless, at 3 h post-exposure
to SaS, the AP-1 transcription factor network was identi-
fied, along with the pro-inflammatory IL-17A pathway
(Table 7). This analysis confirmed the distinct nature of
the responses of MEC to the two stimuli.
Validation of microarray results and quantification by
RT-qPCR or ELISA
RT-qPCR or ELISA validation confirmed the microarray re-
sults. Preliminary experiments indicate that TNF-α tran-
script levels increased following stimulation of bMEC with
LPS and SaS (results not shown). Up-regulation of the gene
encoding TNF-α (TNFa or TNFSF2) was not detected in
the microarray analysis, because the number of validated
observations was insufficient (< 16 validated spots). Quanti-
fication by RT-qPCR of the expression of TNFa shows that
it increased significantly at 3 h and 6 h post-exposure to
LPS and at 3 h post-exposure to SaS (Figure 4). Expression
tended to be higher at 3 h than at 6 h, and with LPS
than with SaS. The same pattern was obtained with IL6
transcripts (Figure 4). It is noteworthy that the cytokines
TNF-α and IL-1β were not detectable by ELISA in the su-
pernatants of bMEC stimulated with LPS or with SaS.
Stimulated bMEC secreted CXCL8, with LPS inducing a
higher response (median value 7846 pg/mL; range 3915 –
9323 pg/mL), than SaS (median 1721; range 1181 –
3090 pg/mL) (p < 0.01, n = 7, Wilcoxon test), after 8 h of
incubation with the agonists, again indicating that LPS
was a stronger inflammatory stimulus than SaS. Tran-
scripts of 3 other chemokines were quantified by RT-
qPCR, including CCL2 and CCL20 which were among the
most up-regulated in the microarray analysis (Figure 4
and Tables 4 and 5) following stimulation with LPS and
SaS. The results of RT-qPCR confirmed this observation,
showing that the response was significantly higher with
LPS than with SaS (Figure 4). Although Ccl2 up-
regulation had not been detected in the microarray ana-
lysis following 3-h exposure to LPS, it was by RT-qPCR.
Also, increases in Ccl2 expression following exposure to
SaS were of limited magnitude and not statistically signifi-
cant. The chemokine CCL5 (also known as RANTES)
appeared in the list of genes up-regulated by LPS but not
by SaS (Tables 4 and 5). This result was confirmed by RT-
qPCR, which showed a marked upregulation of CCL5
transcription with LPS but not with SaS (Figure 4).
The expression of Nos2a, a gene associated with the
innate immune response encoding the inducible nitric
Figure 3 Venn diagrams showing differentially expressed genes as a function of time and stimulus. Upper row: all DEG. Lower row:
up-regulated annotated genes only. The lists of the sets of genes up-regulated on exposure to both SaS and LPS are given. Venn diagrams
composed with VENNY [38]. List of the 16 upregulated annotated genes shared in LPS 3 h and SaS 3 h: CCL20, CXCL8, IL6, CD83, CXCL1, NFKBIA,
CXCL3, BIRC3, SLCO4A1, PLAUR, IER3, ARRDC4, CEBPD, SGK1, BTG3, GABARAPL1. List of the 22 upregulated annotated genes shared in LPS 6 h
and SaS 6 h: CCL20, CXCL8, CXCL5, NOS2A, CCL2, CXCL2, CFB, SGK1, NFKBIA, CD83, ARRDC4, SLC25A28, SAT1, IKBKAP, GABARAPL1, CALCOCO2,
PLAUR, LEPROT, DUSP1, TLR4, CEBPD, SNRNP27.
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Table 4 Genes most significantly differentially expressed by bMEC stimulated by LPS for 3 and 6 h compared to
unstimulated cells, ordered by functional classes
Gene symbol Gene description Fold change
3 h 6 h
Transcription and activation pathways
NFKBIA Nuclear factor of kappa light polypeptide gene enhancer in
B-cells inhibitor, alpha
3.60 4.53
BIRC3 Baculoviral IAP repeat-containing protein 3 3.10 3.19
ZNFX1 NFX1-type zinc finger-containing protein 1 3.11
ZNHIT3 Zinc finger HIT domain-containing protein 3 2.48 3.08
IKBKAP Inhibitor of kappa light polypeptide gene enhancer in B-cells,
kinase complex-associated protein
2.52 2.33
TRIM21 Tripartite motif-containing protein 21 1.61 2.26
CEBPD CCAAT/enhancer binding protein (C/EBP), delta 2.02 1.60
NFKB2 Nuclear factor of κ light polypeptide gene enhancer in B-cells 2 1.78 1.94
JAK2 Janus kinase 2 1.90 1.85
DUSP1 Dual specificity phosphatase 1 1.85
FOS V-fos −2.01
PLK2 Serum-inducible kinase, transcript variant 1,PLK2 −1.50
Cytokines and chemokines, growth factors
CCL5 RANTES 7.10 20.52
CCL20 Chemokine (C-C motif) ligand 20 19.42 19.37
CXCL8 Chemokine (C-X-C motif) ligand 8, Interleukin-8 8.53 13.96
CXCL5 Chemokine (C-X-C motif) ligand 4.75 7.96
CCL2 Chemokine (C-C motif) ligand 2 6.38
CXCL2 Chemokine (C-X-C motif) ligand 2 5.06
CXCL1 Chemokine (C-X-C motif) ligand 1 4.93
IL6 Interleukin 6 6.64 4.85
CXCL3 Chemokine (C-X-C motif) ligand 3 3.15 3.60
IL1B Interleukin 1, beta 5.01 3.32
IFNB Interferon beta precursor 4.89 3.25
TNFSF13B Tumor necrosis factor (ligand) superfamily, member 13 (BAFF) 2.96
IL2 Interleukin 2 4.30 2.86
CCL16 Chemokine (C-C motif) ligand 16 2.60 2.77
CSF2 Colony stimulating factor 2 (granulocyte-macrophage) 1.69 2.10
IL23A Interleukin 23, alpha subunit p19 2.06
CTGF Connective tissue growth factor −1.92
TGFB2 Transforming growth factor beta-2 precursor −1.46
Type I IFN-related genes
IFIT3 Interferon-induced protein with tetratricopeptide repeats 3 3.02 7.92
MX1 Myxovirus (influenza virus) resistance 1 1.84 2.93
IFIH1 Interferon induced with helicase C domain 1 2.65 4.10
ISG15 ubiquitin-like modifier 2.46 3.69
GBP1 Interferon-induced guanylate-binding protein 1 2.17 3.56
TNFSF10 Tumor necrosis factor ligand superfamily member 10 (TRAIL) 2.02 3.13
IFI44 Similar to Interferon-induced protein 44 3.23
OAS1 2′-5′-oligoadenylate synthetase 1 1.61 3.15
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oxide synthase, was up-regulated by LPS and SaS in the
microarray analysis (Tables 4 and 5). Quantification by
RT-qPCR confirmed the increases in transcript numbers
and showed that LPS induced a significantly higher in-
crease (p < 0.05) at both 3 h and 6 h post-exposure than did
SaS (Figure 4). Since the up-regulation of CD83 (Tables 4
and 5) was somewhat unexpected as this gene is mainly
expressed by antigen-presenting cells [40], its expression
was checked by RT-qPCR. The results indicate that tran-
script numbers were significantly increased only by LPS,
at both 3 h and 6 h post-exposure (Figure 4).
Putative contribution of type I IFN to the LPS-induced
response of bMEC
The increased expression of type I IFN-related genes by
LPS most likely resulted from the activation of the
Table 4 Genes most significantly differentially expressed by bMEC stimulated by LPS for 3 and 6 h compared to
unstimulated cells, ordered by functional classes (Continued)
IFI27L1 Interferon alpha-inducible protein 27-like protein 1 2.88
IRF7 Interferon regulatory factor 7 1.45 2.75
TRIM21 Tripartite motif-containing protein 21 1.61 2.26
GVIN1 GTPase, very large interferon inducible 1 2.21
STAT2 Signal transducer and activator of transcription 2 2.01
STAT1 Signal transducer and activator of transcription 1 1.96
IRF2 Interferon regulatory factor 2 1.84
Immune defense response
NOS2A Nitric oxide synthase 2A (inducible) 5.57 7.45
S100A8 Calcium-binding protein A8, calgranulin A 2.87 7.00
CFB Complement factor B 3.39 5.02
S100A9 Calcium-binding protein A9, calgranulin B 2.40 4.59
CD83 Cell surface protein HB15 5.50 3.40
C2 C2 Complement component 2 1.79 2.64
ICAM1 Intercellular adhesion molecule 1 2.50
LTF Lactotransferrin 2.47
PLAT Plasminogen activator, tissue type 1.93 2.11
PLAUR Urokinase plasminogen activator surface receptor 2.11 1.96
CAMP Cathelicidin antimicrobial peptide 1.89
TLR4 Toll-like receptor 4 1.62 1.81
MMP9 Matrix metallopeptidase 9 1.77
CD74 Major histocompatibility complex, class II invariant chain 1.75
BNBD10 Beta-defensin 10 1.59 1.67
Stress response
SOD2 Superoxide dismutase 2 3.19 5.05
SGK1 Serum/glucocorticoid regulated kinase 1 1.81 4.79
PARP14 Poly (ADP-ribose) polymerase family, member 14 2.95
Cell growth and cycle, apoptosis
IGFBP3 Insulin-like growth factor binding protein-3 2.38 5.27
EIF4E Translation initiation factor 4E 2.32 5.20
CASP4 Caspase-4 Precursor 1.60 3.04
CASP8 Caspase-8 precursor 1.58 2.29
IER3 Immediate early response 3 2.09
TNFRSF6 TNF receptor superfamily, member 6 (FAS) 1.82 1.86
CDK2AP1 Cyclin-dependent kinase 2 associated protein 1 −1.66
EI24 Etoposide-induced protein 2.4 homolog −1.65
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Table 5 Genes most significantly differentially expressed by bMEC stimulated by SaS for 3 and 6 h compared to
unstimulated cells, ordered by functional classes
Gene symbol Gene description Fold change
3 h 6 h
Transcription and activation pathways
FOS Proto-oncogene protein c-fos 2.09 2.21
NFKBIA Nuclear factor of kappa light polypeptide gene enhancer in
B-cells inhibitor, alpha
2.15 2.07
DUSP1 dual specificity phosphatase 1 1.91 1.71
ETS2 erythroblastosis virus E26 oncogene homolog 2 (avian) 1.72
CEBPD CCAAT/enhancer binding protein (C/EBP), delta 1.65 1.59
SQSTM1 sequestosome 1 1.58
BIRC3 Baculoviral IAP repeat-containing 3 1.56
IKBKAP inhibitor of kappa light polypeptide gene enhancer in B-cells,
kinase complex-associated protein
1.49
JUN Jun oncogene 1.57 1.47
NFKB2 nuclear factor of κ light polypeptide gene enhancer in B-cells 2 −2.05
FUS RNA-binding protein FUS −1.82
SFRS3 Splicing factor, arginine/serine-rich 3 −1.71
SFPQ splicing factor proline/glutamine-rich −1.59
RABL3 RAB, member of RAS oncogene family-like 3 −1.57
U2AF1 Splicing factor U2AF −1.54
CSTF2 cleavage stimulation factor, 3′pre-RNA, subunit 2 −1.53
RDBP RNA-binding protein RD, Negative elongation factor E −1.47
DKC1 dyskeratosis congenita 1, dyskerin −1.47
CRSP9 Cofactor required for Sp1 transcriptional activation subunit 9 −1.45
Cytokines and chemokines
CXCL8 Chemokine (C-X-C motif) ligand 8, Interleukin-8 6.20 4.52
CCL20 chemokine (C-C motif) ligand 20 4.94 4.27
CXCL1 Chemokine (C-X-C motif) ligand 1 3.51
CXCL3 Chemokine (C-X-C motif) ligand 3 2.48
CCL2 chemokine (C-C motif) ligand 2 2.22 2.71
CXCL5 chemokine (C-X-C motif) ligand 5 2.57
CXCL2 chemokine (C-X-C motif) ligand 2 2.47
IL6 Interleukin 6 1.71
VEGFB Vascular endothelial growth factor B Precursor 1.47
Immune defense response
PLAUR urokinase plasminogen activator surface receptor 1.70 2.46
LBP lipopolysaccharide binding protein 2.26
NOS2A Nitric oxide synthase 2A (inducible) 2.05
CD83 Cell surface protein HB15 1.89 1.73
CFB complement factor B 1.70
SQSTM1 sequestosome 1 1.58
TLR4 toll-like receptor 4 1.50
ILRAP interleukin 1 receptor accessory protein 1.44
CD96 Cell surface antigen CD96 1.31
C3 Complement factor 3 −1.35
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MyD88-independent IFN regulatory factor 3 (IRF3) sig-
naling pathway of TLR4. This pathway leads to the nu-
clear translocation of IRF3 which binds to IRF-binding
sites in the regulatory region of a number of so-called
IFN-regulated genes, although IFN is not involved at this
primary stage. Among the primary response genes is the
gene encoding IFN-β, present as multiple copies in Bos
Taurus [41], which creates a positive autocrine/paracrine
feedback loop through the secretion of IFN-β, engage-
ment of the IFN type I receptor (IFNAR) and binding of
transcription factors to IFN-stimulated response ele-
ments (ISRE) or more generally IFN regulatory factor
binding sites (IRFBS) [42]. As a result, secondary re-
sponse genes are overexpressed [43]. We aimed to check
whether bMEC respond to type I IFN by overexpressing
IFN-related primary and secondary response genes.
Preliminary experiments were carried out to determine
the working concentration of IFN-β, genes suitable as
readouts, and the window time of response. Among sev-
eral sources of ovine, bovine and human type I IFN, re-
combinant human IFN-β was the most active on bMEC
(results not shown). The IFN-inducible genes Isg15 and
Cxcl10 proved to be appropriate readouts for response to
IFN-β yielding marked increased expression at 3 h of incu-
bation with 10 ng/mL IFN-β or more (Figure 5a). The
response to IFN-β decreased by 6 h of incubation
(Figure 5a). Subsequently, the concentration of 10 ng/mL
IFN-β was preferred because it is more in the physio-
logical range. To mimic the effect of a postulated secretion
of type I IFN in response to LPS stimulation, IFN-β
(10 ng/mL) was added to MEC after 3 h of incubation
with SaS, and the cells were incubated for a further 3 h.
Control cells were incubated with medium alone or with
medium plus LPS. Incubation with LPS induced an
overexpression of Cxcl10 and Isg15, whereas incubation
with SaS did not (Figure 5b). The addition of IFN-β during
the incubation increased the expression of these two genes
5 to 6 fold (Figure 5b), indicating that IFN-β was active
under these conditions. Nevertheless, the expression of
Ccl5, Ccl2 and Nos2a was not increased by the addition of
IFN-β to SaS (Figure 5c). This suggests either that the ex-
pression of these genes is less dependent on type I IFN
than are Cxcl10 or Isg15, or that SaS inhibited the effect of
IFN-β on bMEC. It also suggests that the overexpression
of Ccl2, Ccl5 and Nos2a induced by LPS did not depend
on an induced secretion of type I IFN, but rather that
these genes behaved as primary response genes, presum-
ably responding to LPS stimulation through the TLR4-
related IRF3 pathway.
Discussion
Mastitis caused by E. coli is usually clinical and short-lived
due to self-cure whereas S. aureus commonly elicits mild
clinical chronic mastitis. We and others are aiming to im-
prove our knowledge of mammary gland immunity by
contrasting the response of the mammary gland or mam-
mary cells to these two pathogens [5,6,10,13,14,22,44,45].
In this study, we compared the response of bMEC to bac-
terial products released by multiplying E. coli or S. aureus.
The mastitis-causing pathogens E. coli and S. aureus
which have penetrated into the lumen of the mammary
gland are able to grow and multiply in milk with com-
parable generation time and concentration plateau [46].
Consequently the difference in severity and outcome of
infections depends at least in part on the way the two
pathogens are perceived and dealt with by the mammary
gland. Following experimental infusion of small numbers
of bacteria through the teat canal, several hours elapse
before the first signs of inflammation manifest them-
selves [47]. During this lag phase, bacteria are likely to
produce immunomodulins such as MAMP and virulence
factors. We decided to investigate the response of the
most abundant sentry cells in the mammary gland, i.e.
MEC, to bacterial compounds representative of these re-
leased molecules. A crude LPS preparation was chosen
as E. coli stimulus, and an early culture supernatant as
S. aureus stimulus. Since we were interested in the early
response of bMEC to S. aureus, we speculated that the
supernatant from exponential or post-exponential cul-
ture phase would be more representative of the initial
Table 5 Genes most significantly differentially expressed by bMEC stimulated by SaS for 3 and 6 h compared to
unstimulated cells, ordered by functional classes (Continued)
MMP9 Matrix metallopeptidase 9 −1.33
Stress response
SGK1 serum/glucocorticoid regulated kinase 1 1.73 1.75
Cell growth and cycle, apoptosis
IER3 immediate early response 3 1.99 1.58
RASSF1 Ras association domain-containing protein 1 1.52
CDKN2B cyclin-dependent kinase inhibitor 2B −1.85
CDC20 cell division cycle 20 homolog (S. cerevisiae) −1.60
CCNA2 cyclin A2 −1.37
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phase of infection rather than the supernatant of the sta-
tionary phase. Among MAMP detected in these stimuli,
TLR4 and TLR2 agonists were present in the crude LPS
preparation, and TLR2 agonists in the SaS. We identified
LTA as one potential TLR2 agonist, but it is likely that li-
poproteins were also major agonists in SaS [48]. Staphylo-
cocci are known to produce a number of agonists of the
innate immune system [18]. We investigated the presence
and potential activity of two of them, SpA and α-
hemolysin. These two virulence factors were present in
the 8-h SaS, and both were sensed by bMEC as shown by
induction of CXCL8 secretion (Figure 2). Although these
responses were not documented with MEC before, they
are not unexpected. For example, SpA has been shown to
induce CXCL8 production by activating TNFR1 signaling
[49], and bMEC respond to TNF-α [50,51]. Alpha-
hemolysin has been reported to induce CXCL8 in bMEC
when used in association with heat-killed S. aureus [52].
Stimulation of epithelial cells by α-hemolysin could result
from its pore-forming activity and the osmotic stress that
ensues [37,53].
The response of bMEC to SaS was not the result of an
overwhelming cytotoxicity, because the early response
was an increase of the reduction activity (AlamarBlue),
in keeping with the early overexpression of the cyto-
chrome genes cyp1a1 and cyp1b1 induced by killed
S. aureus or S. aureus supernatant [14,17]. Nevertheless,
toxicity is likely to have contributed to shaping the re-
sponse of bMEC to SaS. Apart from genes linked to oxi-
dative stress, genes associated with cyclins and the cell
cycle were differentially expressed after exposure to SaS
(Table 7), which is in keeping with the results obtained
after exposure of sheep MEC to S. aureus supernatant
[17]. This cell response is likely to be a defense response
to the activity of cytotoxic components secreted by
Table 6 Functional pathways of genes most affected by
LPS stimulation, determined by using the Genomatix
Pathway System (GePS)
LPS vs Ref 3 h
(List of 147 genes taken into account)
p value nb of
genes*
Signal transduction pathways (canonical)
Fas signaling pathway 7.58 × 10-6 5/20
Signal transduction pathways (Genomatix) p value nb of
genes
NF kappa B 1.52 × 10-12 41/1542
Signal transducer and activator
of transcription
1.76 × 10-12 36/1184
Toll like receptor 2.49 × 10-12 26/593
Apoptosis 7.27 × 10-12 52/2592
Tumor protein p53 8.23 × 10-12 34/1108
Interleukin 1 2.05 × 10-11 27/706
Janus kinase 2.57 × 10-11 26/657
Tumor necrosis factor 5.10 × 10-11 34/1182
Interleukin 6 5.57 × 10-11 26/680
Inflammatory 8.31 × 10-11 33/1133
Nuclotide oligodimerization domain/ 9.52 × 10-11 13/131
Caspase recruitment protein family
Molecular functions (GO)
Cytokine receptor binding 2.29 × 10-9 12/187
Receptor binding 9.83 × 10-9 23/917
Cytokine activity 5.22 × 10-8 11/199
Chemokine activity 4.88 × 10-7 6/47
Chemokine receptor binding 9.02 × 10-7 6/52
Biological processes (GO)
Immune system process 2.27 × 10-11 28/1094
Immune response 2.98 × 10-10 22/736
Locomotion 2.72 × 10-9 19/605
Multi-organism process 8.37 × 10-9 21/800
Response to chemical stimulus 1.67 × 10-8 28/1461
LPS vs Ref 6 h (List of 193 genes taken into
account)
Signal transduction pathways (Genomatix)
Signal transducer and activation 8.41 × 10-17 44/1184
NF-kB 2.66 × 10-16 49/1542
Chemokine (CC motif) ligand 2 8.63 × 10-16 23/272
Interleukin 6 1.91 × 10-15 33/680
Toll like receptor 2.39 × 10-15 31/593
Immune 4.25 × 10-15 38/957
Inflammatory 4.85 × 10-15 41/1133
Tumor necrosis factor 2.14 × 10-14 41/1182
Interleukin 1 2.87 × 10-13 31/706
Table 6 Functional pathways of genes most affected by
LPS stimulation, determined by using the Genomatix
Pathway System (GePS) (Continued)
Janus kinase 2.89 × 10-13 30/657
Molecular functions (GO)
Cytokine activity 1.21 × 10-10 14/199
Receptor binding 3.74 × 10-9 25/917
Cytokine receptor binding 7.90 × 10-9 12/187
Protein binding 5.75 × 10-6 80/8067
Biological processes (GO)
Immune response 1.59 × 10-14 29/736
Immune system process 3.15 × 10-13 33/1094
Response to stress 1.53 × 10-12 42/1880
Defense response 2.45 × 10-12 26/708
Response to stimulus 2.98 × 10-11 58/3713
* Nb of genes: number of genes in the list/number of genes in the pathway.
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S. aureus and is likely to differ among strains according
to their virulence potential.
A previous study based on the use of ovine MEC cul-
tured under conditions comparable to those of the present
study allowed the comparison of the trancriptomic profiles
of MEC exposed to either live S. aureus or S. aureus cul-
ture supernatant [17]. This study showed that almost half
(286/646) of the DEG were shared between the two stim-
uli. Nevertheless, the greater difference in response to the
two stimuli was manifested at the earlier stimulation time
(1 h) and not at 5 h of stimulation. The different physical
characteristics of the stimuli (particulate versus soluble)
may play a role in these observed early differences.
Exposure of bMEC to LPS or SaS induced the differen-
tial expression of hundreds of genes (Table 3). Transcrip-
tional profiling studies have demonstrated that cells
implicated in immune defenses (including epithelial cells)
respond to bacterial stimuli with common transcriptional
activation programs, which are interpreted as generic
“alarm signals” for infection [54]. Variations on this com-
mon transcriptional theme result from cell type-specific
and pathogen-specific responses. The initial common host
response is largely characterized by features of the innate
immune response [55]. The common host transcriptional
response includes genes that mediate inflammation, genes
that regulate inflammation, genes that activate the local
innate defenses, genes that activate the systemic immune
response, and genes that limit the immune response. All
of these categories were represented in the set of differen-
tially expressed genes by bMEC in response to either LPS
or SaS (Tables 4 and 5). An example is the complement
factor B, an important component of the alternative path-
way of complement activation, which was one of the most
up-regulated genes by both LPS and SaS (Tables 4 and 5).
Up-regulation of components of the alternative pathway
of complement has been reported by others [11], and is in
keeping with the capacity of this pathway to operate in
milk [56].
In previous publications reporting the response of bMEC
to E. coli or S. aureus or TLR agonists such as LPS or LTA,
innate immune genes were among the most numerous and
most up-regulated genes [10,11,45]. TLR signaling via
Myd88 activates two major pathways leading to transcrip-
tional activation in the nucleus: the NF-κB pathway and
the mitogen-activated protein kinase (MAPK) cascade.
The intensity and duration of this activation has to be con-
trolled to avoid excessive inflammatory tissue damage, and
a range of regulatory factors are set in motion to restrict
activation. It is thus not unexpected that NFKBIA tran-
scription was increased by LPS and SaS (Tables 4 and 5). It
has been shown that activation of the NF-κB protein com-
plex closely correlates with the transcriptional level of
NFKBIA [57]. NFKBIA, which encodes IκBα, is involved in
the negative regulation of NF-κB transcription factors. LPS
Table 7 Functional pathways of genes most affected by
SaS stimulation, determined by using the Genomatix
Pathway System (GePS)
SaS vs Ref 3 h
(List of 65 genes taken into account)
p value nb of
genes
Signal transduction pathways (canonical)
AP-1 transcription factor network 5.05 × 10-7 6/69
Signal transduction pathways (Genomatix)
Interleukin 17A 8.75 × 10-7 7/137
Protein kinase B 1.59 × 10-6 9/297
Baculoviral IAP repeat containing protein, 1.94 × 10-6 9/304
apoptosis inhibitor
FBJ murine osteosarcoma viral oncogene 6.49 × 10-6 4/32
homolog B
Cyclin D1 7.69 × 10-6 10/461
Chemokine (CC motif) ligand 2 8.40 × 10-6 8/272
Molecular functions (GO)
Too few genes, p value > 10-5
Biological processes (GO)
Too few genes, p value > 10-5
SaS vs Ref 6 h (213 genes taken into account)
Signal transduction pathways (canonical)
Too few genes, p value > 10-5
Signal transduction pathways (Genomatix)
Minichromosome maintenance complex 6.13 × 10-7 7/42
Cyclin B1 9.29 × 10-7 10/112
Cyclin D1 2.34 × 10-6 19/461
DNA repair 4.43 × 10-6 23/725
Cyclin A2 4.37 × 10-6 11/167
Checkpoint 2.51 × 10-5 16/402
Interleukin 17A 4.07 × 10-5 10/137
Nuclear receptor subfamily 3, group C 4.08 × 10-5 10/171
Cell cycle 4.94 × 10-5 32/1309
Aryl hydrocarbon receptor 9.93 × 10-5 10/190
Molecular functions (GO)
Protein binding 2.95 × 10-5 100/8067
Protein heterodimerizaton activity 1.23 × 10-4 9/202
Oxidoreductase activity 2.39 × 10-4 17/685
Biological processes (GO)
Symbiosis, encompassing mutualism 2.15 × 10-5 6/58
Viral reproduction 3.84 × 10-5 7/94
Cell death 1.05 × 10-4 27/1275
Death 1.10 × 10-4 27/1279
Response to organic substance 1.24 × 10-4 21/874
Oxidation reduction 1.98 × 10-4 17/645
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induces the degradation of the negative regulator IκBα,
allowing NF-κB to translocate in the nucleus, which in turn
triggers a negative feedback loop by promoting the
resynthesis of IκBα [58]. In the same vein, it is noteworthy
that DUSP1 was up-regulated in MEC after stimulation
with SaS (Table 5). The termination of MAPK activity
largely relies on dual specificity phosphatases (DUSP),
whose prototypic member, DUSP1, has been shown to be
expressed in several cell types upon stimulation with LPS
or peptidoglycan, and to contribute to the control of in-
flammation [59,60]. The up-regulation of fos and jun by
SaS (Table 5) at 3 h and 6 h post-stimulation was remark-
able, inasmuch as LPS down-regulated fos at 6 h post-
stimulation (Table 4). The fos gene encodes a leucine
zipper protein that can dimerize with proteins of the Jun
family, thereby forming the transcription factor complex
AP-1. Staphylococcus aureus virulence factors were shown
to induce c-fos expression [61]. The expression of ELRCXC
chemokines by human mammary epithelial cells is mainly
correlated to the AP-1 pathway and to a lesser extent to
the NF-κB pathway [62], which is in line with the stimu-
lated expression of CXCL1, CXCL2, CXCL3, CXCL5 and
CXCL8 by SaS (Table 5). An early activation of NF-κB has
been evidenced in mouse mammary glands after inocula-
tion with E. coli, and molecular imaging showed that this
activation occurred first within the mammary epithelium
[63]. Induction of NF-κB components and of NFKBIA was
also reported early (4 h) after infusion of LPS into mouse
mammary glands [64]. Thus the results obtained in vitro
with bovine MEC are corroborated by data obtained
in vivo with mouse mastitis models.
A major finding of the microarray analysis was that sev-
eral genes of the type I IFN cascade were up-regulated fol-
lowing stimulation with LPS (Table 4), whereas none of
these genes were up-regulated following stimulation with
SaS (Table 5). In macrophages, TLR2 agonists induce a
subset of TLR4-inducible proinflammatory genes, which
suggests the use of differential signaling pathways [65].
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Figure 4 Analysis by RT-qPCR of the expression of a set of genes showing differential expression in the microarray analysis. Relative
quantification of the TNFa, IL6, Ccl2, Ccl5, Ccl20, Nos2 and CD83 transcripts by RT-qPCR 3 h or 6 h after stimulation of bMEpC with LPS or SaS. Median
values (Q1 and Q3) from bMEpC of five cows are shown. * Statistical significance relative to Control. § Statistical significance, LPS versus SaS.
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TLR2 agonists poorly induce IFN-β. LTA in particular did
not induce IFN-β expression [66]. By contrast, the LPS-
induced TLR4 signaling cascade comprises two pathways:
a MyD88-pathway with rapid activation of NF-κB and
MAPK, and a MyD88-independent pathway leading to the
induction of IFN-inducible genes [67]. A considerable part
of the gene expression signature in LPS-stimulated cells
depends on Interferon-stimulated genes (ISG) [43]. IFN
induction plays an important role in activating the full
NF-κB transcriptional response because of transcriptional
cooperation between the IRF and NF-κB [58]. A good ex-
ample of an IFN-dependent gene is Nos2, because full
transcriptional induction of the Nos2 gene encoding the
inducible nitric oxide synthase (iNOS) requires type I IFN
signaling and additional signals emanating from pattern
recognition receptors [68,69]. Up-regulation of Nos2 by
staphylococcal LTA occurs, driven by the stimulation of
the receptor for the platelet activating factor (PAFR)
[66], but LTA did not activate PAFR on bMEC [33]. This
is consistent with our observation that Nos2 was much
more differentially expressed by LPS-stimulated than by
SaS-stimulated MEC (Figure 5c). An increase in Nos2
expression in mammary tissue has been reported fol-
lowing infusion with LPS [70].
A consequence of type I IFN cascade triggering by LPS
but not by SaS was the differential expression of a number
of chemokines encoded by type I IFN responsive genes.
These chemokines are dependent on the type I IFN path-
way for optimal production. The chemokines CXCL10,
CXCL11, CCL2 and CCL5, which are part of the “type I
IFN chemokine signature”, mainly attract monocytes, nat-
ural killer cells and activated lymphocytes [71,72]. Apart
from mononuclear leucocytes, CXCL10, which was highly
up-regulated by LPS but not by SaS (Figure 5b), is also im-
plicated in the recruitment and activation of neutrophils
at sites of infections in mice and humans [73,74]. Of note,
CXCL10 has been found among the highest upregulated
genes in the mammary gland of mice 4 h after infusion
with E. coli LPS [64]. The chemokine CCL20, which at-
tracts memory T lymphocytes and immature DC, depends
on NF-κB and type I IFN pathway for full expression [75].
Our RT-qPCR experiments indicated that Ccl2, Ccl5 and
xCcl20 were more up-regulated by LPS than by SaS
(Figure 4). A higher expression of Ccl5 following stimula-
tion of bMEC with E. coli than with S. aureus has been
reported previously [76]. The differential expression of
these IFN-regulated chemokines may entail a stronger re-
cruitment of monocytes and lymphocytes in the mammary
tissue and milk with LPS than with SaS. More generally,
Type I IFN signaling is considered crucial for host resist-
ance against different pathogens, including extracellular
bacteria such as E. coli and Streptococcus agalactiae [77],
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Figure 5 Effect of IFN-β alone or in combination with SaS on the expression of IFN-inducible genes by bMEC. a) Response of bMEC to
increasing concentrations of recombinant human IFN-β. After 3 or 6 h of incubation with IFN-β, the relative expression of the Cxcl10 and Isg15
genes was determined by RT-qPCR. b) Effect of adding IFN-β (10 ng/mL) to SaS after 3 h of exposure to SaS, and comparison with the effect on
Cxcl10 and Isg15 expression of SaS and LPs alone, measured 3 h after addition of IFN-β. c) Effect of adding IFN-β as in b) on the expression of
Ccl5, Ccl2 and Nos2a. * P < 0.05, relative to Medium; $ P < 0.05, LPS versus SaS.
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although the end-result can be favorable or detrimental to
the host, depending on the circumstances [42].
Several studies have demonstrated that S. aureus acti-
vates IFN-dependent genes [25,78]. The capacity to acti-
vate the type I IFN pathway may be linked to the
expression of virulence genes by live S. aureus [25], be-
cause killed S. aureus do not induce an inflammatory
response as strong as do live bacteria [79,80]. Some expres-
sion of the type I IFN pathway upon stimulation of MEC
with SaS could have been expected, because SpA was
found in SaS, and SpA is able to activate the type I IFN
pathway in airway epithelial cells [81]. The SaS used for
our experiments was shown to contain SpA and alpha he-
molysin, yet there was no indication that the type I IFN
pathway was activated. There may even be inhibition of
IFN-β activity on bMEC by SaS (Figure 5). Activation of
IFN-dependent genes may also result from the autocrine/
paracrine stimulation of MEC by the IL-6 and downstream
triggering of the STAT3 signaling pathway as hypothesized
by others [14]). The lack of overexpression of IFN-
dependent genes by S. aureus culture supernatant or live
S. aureus by ovine MEC or human respiratory cells has
also been reported [16,17]. In the study by Günther et al.
[14] involving bMEC, it is of note that overexpression of
IFN-dependent genes was detected after 24 h of exposure
to heat-killed S. aureus. Another group reported the
overexpression of Ccl5 and Cxcl10 only after 24 h of
exposure of bMEC to heat-killed S. aureus [44]. Thus,
IFN-dependent gene stimulation could be a late event in
S. aureus/MEC interaction, on the contrary to the E. coli/
MEC interaction.
Bovine MEC readily produce chemokines in response
to bacterial stimuli, and apparently there is a good cor-
relation between mRNA levels and protein secretion
[22,33]. On the contrary, increases in TNF-α mRNA
transcripts do not imply protein production by bMEC,
as shown previously [33,51] and in this study. In addition
to being regulated at the transcriptional level, TNF-α pro-
duction is subject to translational control. In particular,
the 3′-untranslated region (UTR) of TNF-α mRNA con-
tains an AU rich sequence that imposes a translational
block on the mRNA, and this block is lifted only in cells
able to produce TNF-α in response to the appropriate
stimuli [82,83]. Production of TNF-α by mouse or bovine
MEC has been reported after stimulation with LPS or
live S. aureus, but the secretion was modest, less than
50 pg/mL [15,22,84]. It may be essential for the mammary
gland to keep the expression of TNF-α under tight
a b
Figure 6 Main signaling pathways supposed to be activated in MEC exposed to either E. coli crude LPS (a) or S. aureus culture
supernatant (b). Crude LPS (a simplified substitute of outer membrane vesicles, omv) is sensed by both TLR2 and TLR4, which activates the
NF-κB pathway by the MyD88-dependent pathway. In addition, the TRAM-TRIF-IRF3 pathway leads to the activation of genes that have an
IRF-binding site in their promoter sequence. S. aureus culture supernatant (SaS) is sensed by TLR2 and other unidentified receptors that activate
the NF-κB and AP-1 pathways. As a result, E. coli stimulation induces a higher number of genes (IFN-stimulated genes) than does S. aureus
stimulation. This is exemplified by the overexpression of a panel of chemokine genes that have the potential to recruit a greater variety of
leukocytes (see text). LTA: lipoteichoic acid; MyD88: myeloid differentiation primary-response gene 88; TRIF: TIR-domain-containing adaptor
protein inducing IFN-β; TRAM: TRIF related adaptor molecule; IFR3: IFN regulatory factor 3; IRFBS: IRF-binding site; JNK: Janus kinase; AP-1: activator
protein 1, composed of the Jun and Fos proteins.
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control, because one autocrine effect of this cytokine is to
inhibit the synthesis of caseins by MEC [85]. Secretion of
IL-1β by bMEC has not been reported to date, although
increases in transcript numbers following stimulation with
LPS or LTA is documented [10,11,76]. Maturation and
secretion of IL-1β is known to be dependent on the activa-
tion of the inflammasome and of caspase-1 [86], events
that have not been documented in bMEC.
A functional pathway most affected by SaS was the IL-
17A transduction pathway (Table 7). This does not mean
that IL-17A directly contributed to the response of MEC
to SaS, but that MEC overexpressed several genes asso-
ciated with this pathway. We have recently shown that
bovine MEC respond to bovine IL-17A by producing
chemokines and overexpressing a number of genes re-
lated to innate immune defenses [51], and up-regulation
of the gene coding IL-17A in milk leukocytes from cows
suffering from S. aureus mastitis has been reported
[87,88]. These observations prompt further studies to in-
vestigate the role of IL-17A in the response of the mam-
mary gland to infection.
Inflammatory responses to E. coli and S. aureus mas-
titis differ in several ways. A major difference is the in-
tensity of the systemic and local responses, which is
considered to result from underlying differences in the
magnitude of production of key pro-inflammatory cyto-
kines and chemokines [89]. In particular IL-1β is found
in greater concentration in milk of E. coli mastitis than
in milk of S. aureus mastitis, and TNF-α is found in bo-
vine milk in case of E. coli but not S. aureus mastitis
[5,6]. The inability of bMEC to secrete TNF-α and IL-1β
in response to crude LPS or SaS suggests that these cells
may not be responsible for the difference in production
of these pro-inflammatory cytokines. These cytokines
are likely to be produced by resident or recruited leucocytes
rather than by MEC. The case of CXCL8 is different, be-
cause the higher concentrations found in milk of E. coli
than S. aureus mastitis were mirrored by a higher produc-
tion by bMEC in this study. Given that milk concentrations
detected during the course of E. coli intramammary infec-
tion are comparable with those detected in response to
intramammary infusion of LPS [89], this suggests that
MEC contribute to this difference. Several studies suggest
that MEC contribute to the production of chemokines
found in milk of mammary tissue in the course of mastitis,
even though most of the results are based on mRNA rather
than on protein quantifications [8,10,12,13,22,33,90]. In this
study we found that the chemokine profile induced by the
stimulation of bMEC by LPS and SaS differ in nature and
magnitude. This differential expression may result in part
from the differential expression of IFN-inducible genes,
which clearly sets apart the early responses of bMEC to
LPS and SaS (Figure 6). A consequence of this stimulation
of IFN-inducible genes is the differential expression of a
number of downstream genes such as certain chemokines
(Ccl2, Ccl5), pro-inflammatory genes (IL6) and innate im-
mune defense genes (Nos2a). This in turn is likely to have a
strong influence on the inflammatory and immune re-
sponses to the corresponding pathogens, S. aureus and
E. coli. In particular the wider set of chemokines induced
by LPS is likely to recruit a wider diversity of leucocytes
than could do S. aureus MAMP. Also, self-defense of the
epithelium may be more stimulated by E. coli than by
S. aureus MAMP. These features could contribute to the
different clinical manifestations and outcome of mastitis
caused by these two pathogens. By combining in vitro and
in vivo approaches and using a variety of models, an
improved understanding of the complex interactions of
pathogens with the mammary gland can be anticipated.
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Chemical reduction of growth medium supplemented with AlamarBlue
by bMEC after 3 h and 6 h of exposure to 25% N305 SaS. Results are
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Additional file 4: List of differentially expressed genes. Bovine MEC
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